Now accepting Telehealth appointments. Schedule a virtual visit.
We are pleased to present here the June issue of the CHR VOICE, after which we traditionally start a two-month summer hiatus for this newsletter, returning to our regular monthly publication schedule with the start of the new 2022-2023...
April was a hectic month at the CHR because the deadline period for abstract submission to the Annual Meeting of the ASRM is always hectic.
March was an unusually busy month at the CHR and not only clinically. CHR’s investigators saw several important papers published, with one in NATURE Medicine, in detail presented in the March issue of the VOICE, receiving unusual media attention
Fertility center reports excellent pregnancy and live birth rates from transfers of embryos by preimplantation genetic testing for aneuploidy (PGT-A) reported to be “chromosomal abnormal” and, therefore, at other IVF centers refused transfer
With Spring per schedule knocking on the door, the mood in the world feels anything but spring-like. The deadly and cruel Russian war machine is already for weeks invading the independent country of Ukraine.
In the shortest and traditionally coldest month of the year, we welcome you to the February issue of our monthly newsletter. Hopefully, history will show that we reached a point in the Covid-19 pandemic with more hope than at any time slot before.
With the year 2021 coming to its end, most of us will agree that this was not a very good year to remember. We can only hope that 2022 will allow the world to return to more traditional living and working conditions, schooling, social interactions as well
With Thanksgiving just around the corner, we here at the CHR for the second year in a row are missing out on the hectic last-minute preparations for our annual conference in New York City on reproductive biology and endocrinology, the CHR until 2019 co-hos
We welcome our readers to the October issue of the VOICE, we hope again packed with interesting and relevant information for patients, colleagues, and any other party interested in reproductive sciences and clinical infertility. October is ...
We are pleased to welcome you to the first issue of the VOICE for the academic year 2021/2022. A new publishing team has taken over, and differences in style and content distribution will, therefore, become quickly apparent. Hopefully also very apparent...
Struggles to get to the clinic? Trying to reduce your exposure to COVID-19, as well as other contagious illnesses, and still need to see your doctor? Telehealth is safe and easy — receive quality care from anywhere.
In this section we attempt to draw attention to science papers we perceive as potentially important for the basic understanding of reproductive biology and, therefore, may have translational relevance to ...
Millions of people who until only a few decades ago had no chance of genetic parenthood, now have children of their own.
New York City and a big part of the country are quickly coming back to almost normal, as case numbers, hospitalizations and deaths from COVID-19 are quickly dropping.
Most of the COVID-19 news these days is positive: new infections in the U.S. and countries, like Israel, have been declining rapidly and, with its deaths from the disease.
The appropriate role of profit incentives on medical practice has been, and will remain for some time to come, the central theme in every discussion of national health care, - whatever the system.
Alarming news about declining sperm counts have recently made headlines in medical literature as well as lay media.
New experimental models for human blastocyst-stage embryos (“blastoids”)
Is there a place for DHEA and CoQ10 in women undergoing “planned” egg-freezing?
Two prominent voices in the fertility field known as longstanding supporters of mild ovarian stimulation were at it once again (Nargund and Fauser, Reprod Biomed Online 2020;41:569-571) when publishing an editorial with ...
In a published letter (_Santoro et al Reprod Sciences 2021; https:/doi.org/10.1007/s43032-021-00491-_9), a small group of prominent physicians, scientists, and ethicists in reproductive medicine urged ...
It is 42 years from the birth of the first IVF offspring and the world is now already approaching 10 million IVF births. There are few, if any, new medical treatments that can point toward such enormous success.
Access To Fertility Coverage Expanded By New York State For Same Sex Couples As Part Of 2021 Women’s Agenda And New York Child Parent Security Act (Cpsa) Went Into Effect
In this issue, we continue to offer what we consider the most important news relating to the infertility field and/or reproductive biology in the preceding month.
Important new observations about placental physiology, protecting offspring from viral infections
For some time, obstructive sleep apnea (OSA) has in the literature been considered a risk factor for male infertility; but up to this point it was not very clear ...
No question in IVF has been as thoroughly investigated as this question and the repeated answer has practically always been the same: there is no evidence that even large numbers of repeat IVF cycles increase cancer risks!
That the World Health Organization (WHO) needs help, has been rather obvious for some time. Whether its disastrous performance at the beginning of the COVID-19 pandemic was professional incompetence or ...
Based on feedback from our readers, each month we will be highlighting what we consider the most important news for fertility patients and professionals working in the field.
New York has been only one of three states (the other two being Louisiana and Michigan) without surrogacy law.
It appears that roughly every 10 years somebody notices that, especially in the developed world, too many Cesarean sections (CS) are being performed.
In December, *ASRM issued the first clinical recommendation from its COVID-19 Task Force which “did not recommend withholding the (anti-COVID-19) vaccine from patients who are planning to ...
One could argue that a class-action lawsuit regarding preimplantation genetic testing for aneuploidy (PGT-A) had to happen sooner or later.
Human growth hormone (HGH) has over the last decade returned to popularity in IVF cycles and is increasingly utilized at many IVF centers, including at CHR.
The VOICE is getting an upgrade! Based on feedback from our readers, each month we will be highlighting what we consider the most important news for fertility patients and professionals working in the field.
CHR's embryo donation program utilizes embryos donated anonymously by infertile patients/couples for such a purpose.
Prominent physicians and scientists criticize continued utilization of Preimplantation Genetic Testing for Aneuploidy (PGT-A) in IVF and warn about a new fourth generation test
Dr. Gleicher joins two prominent colleagues in warning against the widespread utilization of PGT-A, in an opinion paper just published in Trends in Molecular Medicine.
EcoDEP, CHR's frozen donor egg program that offers a lower-cost alternative to traditional (fresh) egg donor program, has a limited number of donor eggs immediately available to recipients.
Following the FDA approval this past weekend, vaccinations against the SARS-CoV-2 virus have begun in the U.S.
As we head into the holiday season many of us find ourselves, as we have for some time, ready for the year to end, hoping for a more normal 2021. But what a year 2020 has been!
Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A 4.0): Hard to believe, but IVF centers really use it!
I arrived in New York City (NYC) to start my residency at Mount Sinai Medical Center roughly 46 years ago.
Here is for once a somewhat happy COVID-19 pandemic story. At already somewhat advanced age, I am still an actively practicing physician-scientist in New York City, since April regularly tested ...
One of the most frequently asked question in, likely, every fertility center is this: Doctor, should I change my diet? For the longest time there was really no good answer to this question ...
As we are finalizing this issue of The VOICE, the country has established a new president-elect who will be inaugurated in January.
A question that only recently seemed to have gained popularity is, what does it mean if an IVF center reports high miscarriage rates?
The SARS-CoV-2 virus, causing the current COVID-19 pandemic, is now almost 8 months among us. It has changed everything almost everywhere in the world.
We still have not figured out why, but CHR sees increasing numbers of women who, even at advanced ages, still produce unusually good numbers of eggs.
Harvard University's Petrie-Flom Center is hosing a webinar on IVF add-ons on November 10, 2020 at noon EST. Dr. Gleicher is a panelist on the webinar.
Since our September issue was completely dedicated to COVID-19, here is, for all practical purposes, our first regular issue of the VOICE in the 2020/2021 academic year, and what an academic year ...
CHR recently announced and registered a third PRP trial. For those who do not recall our prior discussions of PRP (platelet-rich plasma) in these pages, here is a quick ...
Mostly unnoticed and/or unmentioned by media, because of what has been happening in many countries to national health care systems (the U.S. included), brought on by the COVID-19 ...
The chance of pregnancy in an IVF cycle, of course, depend on many factors. Two often related factors, however, dominate: female age and functional ovarian reserve.
CHR is please do announce that Mia Yang, PhD, Junior Scientist at CHR and Postdoctoral Associate in the Laboratory of Stem Cell Biology and ...
One of CHR's abstracts accepted to this year's ASRM meeting won the prestigious SRBT Basic Science Award.
Study in NYC suggests that the city, likely, has already reached an adequate level of herd immunity to prevent a significant second wave of COVID-19 in the fall
After a two-month break, we are very pleased to offer here the first issue for the 2020/2021 academic year of CHR’s VOICE.
The COVID-19 pandemic through eyes of a NYC fertility center: A unique learning experience with often unexpected results
The COVID-19 pandemic through eyes of a NYC fertility center: A unique learning experience with often unexpected results
Fertility Treatment at CHR during COVID-19, at a Glance
Evolving understanding of COVID-19 immunity, notable articles in the medical literature and the media, and more.
Over the long July 4th weekend, The New York Times (July 5, 2020, pages 15-18) published a revealing lead article, documenting the stealthy nature of the COVID-19 epidemic in the U.S.
In this month's CHR VOICE, we discuss what it means to "follow science" and continue our series on fertility treatments for women with low functional ovarian reserve.
New study suggests a lower immunity level in the community than the typically quoted 60%, gauged by antibody tests, may be sufficient to protect everyone from COVID-19, as new case numbers surge in southwestern US states.
Not at all unexpected, COVID-19 infections have significantly rebounded with, unquestionably, a very profound degree of community spread being the underlying cause.
Media reports from all over the world suggest that we may be at the beginning of a second COVID-19 wave, while some epidemiologists/public health experts have suggested ...
As New York City enters the Phase II of reopening, are we witnessing the 2nd wave of COVID-19 infections?
WHO was wrong about asymptomatic patients being contagious, and other COVID-19 fake news to watch out for.
Here goes another COVID-19 myth onto the ever-growing heap of false information we have been exposed to since beginning of the pandemic.
While many fertility centers closed down in the first few months of COVID-19 outbreak in the United States, CHR never closed our doors, despite our location in New York City, one of the hardest-hit areas in the country.
3 prominent fertility specialists urge the IVF field to focus on improving autologous IVF pregnancy rates for women over 40, in a newly published paper.
Prominent fertility experts challenge current IVF practice in older women that automatically resorts to third-party egg donation
We here continue the series on how to individualize fertility treatments in women with low functional ovarian reserved (LFOR), often also called diminished ovarian reserve (DOR).
The June issue of this newsletter traditionally is the last before a summer hiatus for the VOICE in July and August.
Sad to acknowledge but necessary to recognize, even the political discourse surrounding the continuous management of the COVID-19 virus has in the U.S. become a political football.
International Do No Harm Group in IVF (IDNHG-IVF), consisting of prominent physicians and basic scientists in reproductive medicine, including CHR physicians, just published a Position Statement on ...
International Group of Prominent Reproductive Physicians and Scientists Releases Position Statement on Chromosomal Testing of Human Embryos Prior to Embryo Transfer
What we now know about COVID-19 and what it means for mitigation strategies going forward.
Though much still remains to be leared about COVID-19, clarity is starting to break through the clouds on a number of important issues.
While COVID-19 still continues to dominate our psyche, we look forward with a first article in a series on DOR/LFOR.
With CHR, likely being an extreme example (median age 43 years), patient populations in many fertility centers are aging, leading to surges in ...
The amount of information distributed in print, social media, Internet and television on the COVID-19 crisis is, likely, unprecedented.
We have repeatedly, and in detail, laid out in these pages and in CHR’s intermittent COVID-19 Bulletins why CHR made the decision to remain open, while most other IVF centers decided to close down. Though it was a controversial decision, we are pleased to
During April, the coronavirus and COVID-19, in all spheres of life, continued to dominate the nation’s existence. That, of course, also applies here at CHR.
As the country is slowly “reopening” it economy, the President’s COVID-19 Task Forece is redirecting its focus by concentrating on this reopening process and on, as quickly as possible, developing an effective vaccine.
ASRM and SART release guidelines on reopening IVF centers that have closed to prevent the spread of COVID-19. CHR has implemented most of the recommended policies as we've remained open.
We are very pleased that the _American Society for Reproductive Medicine (ASRM) _and its daughter society, the _Society for Assisted Reproductive Technology (SART) _on April 24 ...
One of the major problems why COVID-19 is being managed incorrectly almost all over the world, is the extraordinary exaggeration of risk by interested parties.
In an article on April 23 the Daily Beast expanded on the information we provide in CHR’s Bulletin of April 22, in which we reported that autopsies in ...
We have not published a Bulletin for almost a week because there has not much been happening regarding the COVID-19 pandemic.
How can fertility patients decide when to restart their treatments after the current spread of COVID-19 slows down?
Some IVF centers recommend embryo freezing rather than IVF during COVID-19 outbreak. Is this a reasonable approach?
How will fertility centers reopen after the acute phase of COVID-19 pandemic is behind us? This is another frequently asked question and, once again, there is no easy answer since circumstances can and will vary between centers.
Since CHR has been fully functioning throughout the crisis, though, of course, at a much lower patient volume, we have had daily contact with patients.
Something “ funny” has been going on in some IVF center over the last fewe weeks. Quite a number of patients reported that they were advised to freeze their eggs and/or embryos rather than ...
As expected, death rates from COVID-19 in the New York Tristate Area have reached a peak this week. Quite reassuringly, new hospital admissions and admissions into intensive care have dramatically declined, however.
Fertility Providers' Alliance issues new letter attempting to reframe ASRM's reaffirmation of guidelines on COVID-19 and fertility treatment as FPA's victory.
